Chemotherapeutic dihydromyricetin with remarkable anti-tumor activity and biosafety for muscle invasive bladder cancer.
Year: 2025
Type: article
Abstract: anti-tumor activity and biosafety, which could serve as a promising alternative for the application of MIBC chemotherapy.
Source: PubMed
Language: English
Subfield: Complementary and alternative medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4412957801
